Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2
NRG-GU006 trial: what clinicians have said so far
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial
- NCT03371719 ↗
- Active, not recruiting
- NRG Oncology
- Deep size, estimated: 301+ verified statements
We haven't built an HCP commentary report on NRG-GU006 (apalutamide in recurrent prostate cancer) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on NRG-GU006 so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 41 posts on X | |
| 2 YouTube videos | |
| 2 podcast episodes |
The trial
ClinicalTrials.gov- Official title
- A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
- Phase
- Phase 2
- Status
- Active, not recruiting
- Conditions
- Recurrent Prostate Carcinoma; Stage III Prostate Adenocarcinoma AJCC v7; Stage IV Prostate Adenocarcinoma AJCC v7
- Interventions
- Apalutamide; External Beam Radiation Therapy; Placebo Administration
- Arms
- Arm 1 (radiation therapy, placebo) · Active comparator
- Arm 2 (radiation therapy, apalutamide) · Experimental
- Enrollment
- 298
- Primary outcomes
- Percentage of Participants Alive Without Biochemical Progression (Biochemical Progression-free Survival)
- Sponsor
- NRG Oncology with National Cancer Institute (NCI)
- Start
- Jun 20, 2018
- Primary completion
- Mar 10, 2025
- Results posted
- Yes
- Registry record
- NCT03371719 · updated Oct 1, 2026
Publications
linked from the registry- Morgan TM, Boorjian SA, Buyyounouski MK, Chapin BF, Chen DYT, Cheng HH, Chou R, Jacene HA, Kamran SC, Kim SK, Kirkby E, Luckenbaugh AN, Nathanson BJ, Nyame YA, Posadas EM, Tran PT, Chen RC. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions. J Urol. 2024 Apr;211(4):526-532. doi: 10.1097/JU.0000000000003890. Epub 2024 Feb 29. PubMed 38421252
- Morgan TM, Boorjian SA, Buyyounouski MK, Chapin BF, Chen DYT, Cheng HH, Chou R, Jacene HA, Kamran SC, Kim SK, Kirkby E, Luckenbaugh AN, Nathanson BJ, Nyame YA, Posadas EM, Tran PT, Chen RC. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy. J Urol. 2024 Apr;211(4):518-525. doi: 10.1097/JU.0000000000003891. Epub 2024 Feb 29. PubMed 38421243